Navigation Links
Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder
Date:6/12/2008

Reports Full Assessment of Data from Positive Phase 2a Trial

WALTHAM, Mass., June 12 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) today announced that based on feedback from the Food and Drug Administration, the Company plans to initiate a Phase 2b clinical trial of RG2417, an oral formulation of uridine, in patients with bipolar disorder later this year. This will be a multi-center, parallel arm placebo-controlled, clinical trial in which approximately 150 patients with bipolar disorder will receive either RG2417 or a placebo twice a day for eight-weeks. This study is designed to assess the efficacy and safety of RG2417 on the symptom of depression as measured by the Montgomery-Asberg Depression Rating Scale (MADRS). Gary S. Sachs, M.D., founder and director of the Bipolar Clinic and Research Program at the Massachusetts General Hospital and an Associate Professor of Psychiatry at the Harvard Medical School will be the Principal Investigator of this study.

Repligen previously reported positive initial results from a Phase 2a clinical trial of RG2417 in patients with bipolar disorder. We have now completed our assessment of the data and have found that patients with a history of more frequent symptoms demonstrated greater improvements when treated with RG2417 than patients without a history of frequent symptoms. For example, patients with more than 5 episodes of depression over their entire life (n=50) demonstrated greater improvements in their symptoms of depression compared to patients with 5 or fewer lifetime episodes of depression. From weeks 2-6 of treatment, the patients with more than 5 lifetime episodes of depression who received RG2417 had an average improvement on MADRS of 5.5 points over place
'/>"/>

SOURCE Repligen Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Repligen Reports Positive Phase 2a Clinical Trial Results of RG2417 for Symptoms of Bipolar Disorder
2. Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging
3. Repligen Receives FDA Fast Track Designation for RG1068 for Pancreatic Imaging
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 30, 2014 The Chinese wound care market ... rise in the incidence of lifestyle diseases, coupled with ... affordability of better quality of wound care products provide ... coverage of public health insurance schemes and increased reimbursement ... Based on the findings of primary and secondary researches, ...
(Date:9/30/2014)... , N.J. and NEW BRUNSWICK, N.J., Sept. 30, 2014 /PRNewswire-USNewswire/ ... that allows Kessler Foundation and New Jersey Health ... research, education and patient care programs has been ... chief executive officer of Kessler Foundation and ... Health Foundation. "The experience of New ...
(Date:9/30/2014)... 2014 BioStructures, LLC has been awarded ... Tissue Banks (AATB), it was announced today by ... Accreditation follows an intensive nine-month process, including ... inspector.  It establishes that the level of medical, ... or exceeds the standards set by the AATB.  ...
Breaking Medicine Technology:China Wound Care Market 2China Wound Care Market 3Kessler Foundation Partners with New Jersey Health Foundation To Start Innovative Companies To Change the Lives of People with Disabilities 2Biostructures, LLC Earns AATB Accreditation 2
... 13 Rcadia Medical Imaging today announced that ... of coronary CT angiography (cCTA) will be featured in ... scientific meeting of the Society of Cardiovascular Computed Tomography ... .  SCCT is the international professional society representing physicians, ...
... FOREST, Ill. , July 13 ... leading provider of clinical information and medication delivery technologies, ... clinical surveillance system helped clinicians at Memorial ... an increase in infection-control interventions. The hospital, which used ...
Cached Medicine Technology:Rcadia Announces Five COR Analyzer® Studies to be Presented at SCCT Annual Scientific Meeting 2Rcadia Announces Five COR Analyzer® Studies to be Presented at SCCT Annual Scientific Meeting 3Hospira TheraDoc(TM) Infection Control Assistant(TM) Documents Interventions to Help Hospital Reduce Catheter-Related Infections 2Hospira TheraDoc(TM) Infection Control Assistant(TM) Documents Interventions to Help Hospital Reduce Catheter-Related Infections 3Hospira TheraDoc(TM) Infection Control Assistant(TM) Documents Interventions to Help Hospital Reduce Catheter-Related Infections 4Hospira TheraDoc(TM) Infection Control Assistant(TM) Documents Interventions to Help Hospital Reduce Catheter-Related Infections 5Hospira TheraDoc(TM) Infection Control Assistant(TM) Documents Interventions to Help Hospital Reduce Catheter-Related Infections 6
(Date:9/30/2014)... carbon emissions will reduce other harmful air pollution ... a new study released today. The research shows ... the final Clean Power Plan, the power plant ... hospitalizations, and hundreds of heart attacks in the ... Health Co-benefits of Carbon Standards for Existing Power ...
(Date:9/30/2014)... Health Day Reporter ... patients who are overweight or obese when diagnosed appear ... second weight-related cancer, new research suggests. , , The ... recurrence, only the potential for developing other cancers associated ... survivors who reported being overweight or obese prior to ...
(Date:9/30/2014)... the leading cause of cancer death in women, according ... medical professionals encourage women to get mammograms, even though ... of suspicious mammograms actually leads to a cancer diagnosis. ... women and their familiesnot to mention the time, discomfort ... , Recently, a different type of test, ultrasound ...
(Date:9/30/2014)... SILVERTHORNE, CO September 30, 2014 Keystone Symposia ... and the first in its 2014-15 Global Health Series ... at the Sheraton Seattle Hotel immediately following the ... grantees. The four-day conference is part of the Keystone ... Melinda Gates Foundation, which has also funded travel awards ...
(Date:9/30/2014)... September 30, 2014 A new study ... University studied the impact of stress on metabolism after eating ... french fries from a fast food restaurant, about 930 calories ... metabolism for 20 minutes every hour for 7 hours, conducting ... that women who had experienced a stressful event in their ...
Breaking Medicine News(10 mins):Health News:Power plant standards could save thousands of US lives every year 2Health News:Power plant standards could save thousands of US lives every year 3Health News:Obesity Tied to Higher Cancer Risk for Colon Cancer Survivors 2Health News:Obesity Tied to Higher Cancer Risk for Colon Cancer Survivors 3Health News:'Virtual breast' could improve cancer detection 2Health News:Keystone Symposia launches 2014-2015 meeting series with Global Health Vaccines Conference 2Health News:NutriGold Urges Every Woman To Read a Recent Study About Diet and Stress 2Health News:NutriGold Urges Every Woman To Read a Recent Study About Diet and Stress 3
... McCain Health Plan Dismantles Employer-based Health Care, ... Impact, WASHINGTON, April 29 Sen. John ... that covers,more than 60 percent of non-elderly Americans ... responding to the announcement of his proposal,today. An ...
... asked had borrowed, given away allergy pills, antibiotics and ... you,ve ever shared your allergy medicines, antibiotics or even ... plenty of company: A new survey suggests many give ... , However, this can be an extremely bad idea, ...
... (WASHINGTON, D.C. April 29, 2008) The ... week announced grant awards to 46 institutions through ... multi-year, multi-million dollar program, launched in late 2007, ... the salary and benefits for physicians training in ...
... The cost of cancer care for elderly Medicare patients varies ... survival, according to a new study published online April 29 ... The 5-year cost is highest for patients with lung, colorectal, ... care for elderly Medicare patients diagnosed with cancer in 2004 ...
... lung lubricant that premature babies need to help them ... have later, Medical College of Georgia physicians say. , ... air sacs inside the lungs from sticking together when ... causes trauma to the respiratory system and can lead ...
... Open the Door to Personalized Medicine and Represents a ... Seismic Shift for the Pharma ... of Thomson Reuters today announced the launch of a new,biomarkers ... introduction to the world of biomarkers, an overview of,the regulatory ...
Cached Medicine News:Health News:McCain Would Drive Up Health Care Costs for Families, While Benefiting Health Insurance Companies 2Health News:McCain Would Drive Up Health Care Costs for Families, While Benefiting Health Insurance Companies 3Health News:Many Americans Share Prescription Meds 2Health News:SCAI awards 46 grants for interventional cardiology training fellowships 2Health News:SCAI awards 46 grants for interventional cardiology training fellowships 3Health News:Medicare costs estimated to top $21.1 billion for 5 years of care for elderly cancer patients 2Health News:New treatment could reduce chronic lung disease in premature babies 2Health News:New Thomson Reuters Biomarkers Report Shines a Light on Revolutionary New Area of Drug Development 2Health News:New Thomson Reuters Biomarkers Report Shines a Light on Revolutionary New Area of Drug Development 3Health News:New Thomson Reuters Biomarkers Report Shines a Light on Revolutionary New Area of Drug Development 4
Curved left, Hardy Curettes, bayonet, working distance 120 mm, total length 241 mm....
Toothed pituitary rongeur. Straight....
Micro cup pituitary forceps, semi-malleable shafts....
Teardrop dissector. 90, 5 mm....
Medicine Products: